ボディコントゥアリング市場：治療タイプ、技術、エンドユーザー、用途、製品タイプ別-世界予測2025-2030年

ボディコントゥアリング市場は、2023年に3億5,437万米ドルと評価され、2024年には3億8,748万米ドルに達すると予測され、CAGR 11.62%で成長し、2030年には7億6,534万米ドルに達すると予測されています。

ボディコントゥアリングには、人体の外観を整え、より美しくすることを目的としたさまざまな医療処置が含まれます。脂肪吸引やタミータックのような外科的技術と、クールスカルプティングやレーザー治療のような非外科的治療の両方が含まれます。ボディコントゥアリングの世界の需要の高まりは、肥満率の増加、美意識の高まり、非侵襲的施術の技術進歩によって後押しされています。主な用途には、脂肪減少、セルライト治療、肌の引き締め、肌の若返りなどがあり、クリニック、病院、スパなどの顧客に対応しています。健康と並んで外見を優先する人が増えているため、ボディコントゥアリング市場は大きな成長機会に直面しています。重要な促進要因としては、安全性の向上、回復時間の短縮、性別や年齢を問わず美容施術が受け入れられつつあることなどが挙げられます。しかし、課題も残っています。高額な施術費用、厳格な規制遵守、外科的介入による潜在的な副作用などが市場の成長を阻害する可能性があります。さらに、一貫性のない経済状況は、美容整形に対する個人の裁量支出に影響を与える可能性があります。こうしたハードルにもかかわらず、アジア太平洋やラテンアメリカのような地域では、中流階級の人口が急増し、可処分所得が増加しているため、市場は潜在的な可能性を秘めています。企業は、サービスの提供を拡大し、クライオリポライシスや高周波機器のような先端技術に投資することで、こうした機会を活用すべきです。技術革新については、カスタマイズ可能な治療に焦点を当て、AIと機械学習を統合して治療成果を高めることで、市場プレーヤーを差別化できます。痛みのない、効率的で経済的な手技の調査も有望な分野です。ボディコントゥアリング市場の性質はダイナミックで競争が激しく、継続的なイノベーションが市場開拓を促進しています。企業は、消費者の動向を鋭く把握し、デジタル・マーケティングを活用し、強力な顧客教育チャネルを確立して、市場シェアを巧みに維持・拡大する必要があります。

市場力学：急速に進化するボディコントゥアリング市場の主要市場インサイトを公開

ボディコントゥアリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 医療ツーリズム産業の拡大が手頃な価格のサービス需要を牽引
  • ボディコントゥアリングへの関心を高める肥満と関連疾患の発生率の増加
  • ボディコントゥアリング治療を促進するソーシャルメディアや有名人の推薦の影響力
  • ダウンタイムを最小限に抑え、早期回復を可能にする革新的なボディコントゥアリング治療の開発
• 市場抑制要因
  • 潜在的患者のボディコントゥアリング治療に対する認識と知識の不足
  • ボディコントゥアリング施術に伴う潜在的な健康リスクが患者の信頼に影響
• 市場機会
  • 新興諸国におけるボディコントゥアリングの普及率向上による市場開拓
  • 市場シェア拡大と成長につながる、主要企業間の戦略的提携と買収
  • 男性のボディコントゥアリング施術に対する認識と受容の高まりによる新たな市場セグメントの創出
• 市場の課題
  • 市場シェアに影響を与えるクライオリポライシス、超音波、レーザー治療などの非侵襲的脂肪減少治療との競合の増加
  • 高い治療費と保険適用不足がボディコントゥアリング施術を選ぶ患者の意欲を削ぐ

ポーターの5つの力：ボディコントゥアリング市場をナビゲートする戦略ツール

ポーターのファイブフォース（5つの力）は、ボディコントゥアリング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ボディコントゥアリング市場における外部からの影響の把握

外部マクロ環境要因は、ボディコントゥアリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ボディコントゥアリング市場における競合情勢の把握

ボディコントゥアリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスボディコントゥアリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ボディコントゥアリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ボディコントゥアリング市場における成功への道筋を描く

ボディコントゥアリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医療観光産業の拡大により、手頃な価格のボディコントゥアリングサービスの需要が高まっている
    • 肥満および関連疾患の発生率の上昇により、ボディコントゥアリングへの関心が高まっています。
    • ボディコントゥアリング治療を促進するソーシャルメディアと有名人の推薦の影響
    • ダウンタイムを最小限に抑え、迅速な回復を保証する革新的なボディコントゥアリング治療法の開発
  • 抑制要因
    • 潜在的な患者の間でボディコントゥアリング手順に関する認識と知識が限られている
    • 患者の信頼に影響を与えるボディコントゥアリング処置に関連する潜在的な健康リスク
  • 機会
    • 新興諸国では採用率の上昇によりボディコントゥアリング処置の市場が拡大
    • 主要企業間の戦略的提携と買収により、市場シェアと成長が拡大
    • 男性の間でボディコントゥアリング手順の認知度と受容度が高まり、新たな市場セグメントが生まれている
  • 課題
    • 冷凍脂肪溶解療法、超音波療法、レーザー療法などの非侵襲的脂肪減少治療との競合が激化し、市場シェアに影響を及ぼしています。
    • 治療費が高く、保険適用外のため、患者はボディコントゥアリング処置を選択することを躊躇しています。
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ボディコントゥアリング市場治療の種類別

• 侵襲的
  • 下半身リフト
  • 伝統的な脂肪吸引
  • 腹部整形
• 低侵襲
  • レーザー脂肪吸引
  • ラジオ波脂肪吸引
• 非侵襲的
  • 冷却脂肪溶解
  • 高密度焦点式超音波（HIFU）
  • レーザー脂肪分解
  • 無線周波数

第7章 ボディコントゥアリング市場：技術別

• 冷却脂肪溶解
• 注射剤
• レーザ
• 無線周波数
• 超音波

第8章 ボディコントゥアリング市場：エンドユーザー別

• 病院
• メディカルスパ
• 専門クリニック

第9章 ボディコントゥアリング市場：用途別

• 腹部
• 武器
• ボディ＆バック
• 臀部
• 太もも

第10章 ボディコントゥアリング市場：製品タイプ別

• 消耗品
• デバイス

第11章 南北アメリカのボディコントゥアリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のボディコントゥアリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのボディコントゥアリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Aerolase
• 2. Allergan
• 3. Alma Lasers
• 4. BTL Aesthetics
• 5. Cutera
• 6. Cynosure
• 7. EndyMed
• 8. Fotona
• 9. Galderma
• 10. Hologic
• 11. InMode
• 12. Lumenis
• 13. Merz Pharma
• 14. Sciton
• 15. Solta Medical
• 16. Syneron Medical
• 17. ThermiGen
• 18. Valeant Pharmaceuticals
• 19. Venus Concept
• 20. Zimmer Aesthetics

LIST OF FIGURES

• FIGURE 1. BODY CONTOURING MARKET RESEARCH PROCESS
• FIGURE 2. BODY CONTOURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. BODY CONTOURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. BODY CONTOURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BODY CONTOURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BODY CONTOURING MARKET DYNAMICS
• TABLE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY LOWER BODY LIFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY TRADITIONAL LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY TUMMY TUCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER LIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BODY CONTOURING MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BODY CONTOURING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BODY CONTOURING MARKET SIZE, BY ARMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BODY CONTOURING MARKET SIZE, BY BODY & BACK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BODY CONTOURING MARKET SIZE, BY BUTTOCKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGHS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BODY CONTOURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BODY CONTOURING MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CANADA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 69. CANADA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 70. CANADA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 71. CANADA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. CANADA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. CANADA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. CANADA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. AUSTRALIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. CHINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. CHINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 111. CHINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 112. CHINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 113. CHINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. CHINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. CHINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. CHINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. INDIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. INDIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 119. INDIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 120. INDIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 121. INDIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. INDIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. INDIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. INDIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. INDONESIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. JAPAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. MALAYSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. MALAYSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. PHILIPPINES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. PHILIPPINES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SINGAPORE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SINGAPORE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SINGAPORE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. TAIWAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TAIWAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TAIWAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. THAILAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. THAILAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. THAILAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. VIETNAM BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. VIETNAM BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. VIETNAM BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. DENMARK BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. DENMARK BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. DENMARK BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. EGYPT BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. EGYPT BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. EGYPT BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. FINLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. FINLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. FINLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. FRANCE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. FRANCE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. FRANCE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. GERMANY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 244. GERMANY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. GERMANY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. ISRAEL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. ISRAEL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. ISRAEL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. ITALY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. ITALY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 256. ITALY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 257. ITALY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 258. ITALY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. ITALY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. ITALY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. ITALY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. NETHERLANDS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. NETHERLANDS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. NETHERLANDS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. NIGERIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. NIGERIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. NIGERIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 283. NORWAY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. NORWAY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. NORWAY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 286. POLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 287. POLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 288. POLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 289. POLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 290. POLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 291. POLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 292. POLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. POLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 294. QATAR BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. QATAR BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 296. QATAR BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 297. QATAR BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 298. QATAR BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 299. QATAR BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 300. QATAR BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. QATAR BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 305. RUSSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 307. RUSSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 308. RUSSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. RUSSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 318. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 324. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 326. SPAIN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 327. SPAIN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 328. SPAIN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 329. SPAIN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 331. SPAIN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 332. SPAIN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 333. SPAIN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 334. SWEDEN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 335. SWEDEN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 336. SWEDEN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 337. SWEDEN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 338. SWEDEN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 339. SWEDEN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 340. SWEDEN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 341. SWEDEN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 342. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 343. SWITZERLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 344. SWITZERLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 345. SWITZERLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 346. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 347. SWITZERLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 348. SWITZERLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 349. SWITZERLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 350. TURKEY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 351. TURKEY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 352. TURKEY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 353. TURKEY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 354. TURKEY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 355. TURKEY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 356. TURKEY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 357. TURKEY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 358. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 359. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 360. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
• TABLE 361. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
• TABLE 362. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 363. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 364. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY APPLICATION

The Body Contouring Market was valued at USD 354.37 million in 2023, expected to reach USD 387.48 million in 2024, and is projected to grow at a CAGR of 11.62%, to USD 765.34 million by 2030.

Body contouring encompasses a range of medical procedures aimed at reshaping and enhancing the human body's appearance. It involves both surgical techniques, such as liposuction and tummy tucks, and non-surgical treatments, like CoolSculpting and laser therapy. The growing global demand for body contouring is fueled by increasing obesity rates, a rising aesthetic consciousness, and technological advancements in non-invasive procedures. Key applications include fat reduction, cellulite treatment, skin tightening, and skin rejuvenation, catering to clients in clinics, hospitals, and spas. As people increasingly prioritize their appearance alongside health, the body contouring market faces expansive growth opportunities. Significant drivers include improved safety profiles, minimal recovery time, and the increasing acceptance of aesthetic procedures across genders and age groups. However, challenges persist: high procedure costs, stringent regulatory compliance, and potential side effects from surgical interventions can inhibit market growth. Moreover, inconsistent economic conditions might impact individuals' discretionary spending on cosmetic procedures. Despite these hurdles, the market holds potential in regions like Asia-Pacific and Latin America due to burgeoning middle-class populations and increased disposable incomes. Businesses should capitalize on these opportunities by expanding service offerings and investing in advanced technologies like cryolipolysis and radiofrequency devices. For innovation, focusing on customizable treatments and integrating AI and machine learning to enhance procedural outcomes can differentiate market players. Research into pain-free, efficient, and economical procedures is another promising area. The nature of the body contouring market is dynamic and fiercely competitive, with continuous innovations driving market development. Businesses should maintain a keen understanding of consumer trends, leverage digital marketing, and establish strong customer education channels to maintain and expand their market share adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Body Contouring Market

The Body Contouring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding medical tourism industry driving demand for affordable body contouring services
  • Higher incidence of obesity and related conditions leading to increased interest in body contouring
  • Influence of social media and celebrity endorsements promoting body contouring treatments
  • Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
• Market Restraints
  • Limited awareness and knowledge about body contouring procedures among potential patients
  • Potential health risks associated with body contouring procedures affecting patient confidence
• Market Opportunities
  • Emerging market for body contouring procedures in developing countries due to higher adoption rates
  • Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
  • Rising awareness and acceptance of body contouring procedures among men creating new market segments
• Market Challenges
  • Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
  • High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures

Porter's Five Forces: A Strategic Tool for Navigating the Body Contouring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Body Contouring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Body Contouring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Body Contouring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Body Contouring Market

A detailed market share analysis in the Body Contouring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Body Contouring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Body Contouring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Body Contouring Market

A strategic analysis of the Body Contouring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Body Contouring Market, highlighting leading vendors and their innovative profiles. These include Aerolase, Allergan, Alma Lasers, BTL Aesthetics, Cutera, Cynosure, EndyMed, Fotona, Galderma, Hologic, InMode, Lumenis, Merz Pharma, Sciton, Solta Medical, Syneron Medical, ThermiGen, Valeant Pharmaceuticals, Venus Concept, and Zimmer Aesthetics.

Market Segmentation & Coverage

This research report categorizes the Body Contouring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment Type, market is studied across Invasive, Minimally Invasive, and Non-Invasive. The Invasive is further studied across Lower Body Lift, Traditional Liposuction, and Tummy Tuck. The Minimally Invasive is further studied across Laser-Assisted Liposuction and Radiofrequency-Assisted Liposuction. The Non-Invasive is further studied across Cryolipolysis, High-Intensity Focused Ultrasound (HIFU), Laser Lipolysis, and Radiofrequency.
• Based on Technology, market is studied across Cryolipolysis, Injectables, Laser, Radiofrequency, and Ultrasound.
• Based on End-User, market is studied across Hospitals, Medical Spas, and Specialty Clinics.
• Based on Application, market is studied across Abdomen, Arms, Body & Back, Buttocks, and Thighs.
• Based on Product Type, market is studied across Consumables and Devices.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding medical tourism industry driving demand for affordable body contouring services
    • 5.1.1.2. Higher incidence of obesity and related conditions leading to increased interest in body contouring
    • 5.1.1.3. Influence of social media and celebrity endorsements promoting body contouring treatments
    • 5.1.1.4. Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and knowledge about body contouring procedures among potential patients
    • 5.1.2.2. Potential health risks associated with body contouring procedures affecting patient confidence
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging market for body contouring procedures in developing countries due to higher adoption rates
    • 5.1.3.2. Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
    • 5.1.3.3. Rising awareness and acceptance of body contouring procedures among men creating new market segments
  • 5.1.4. Challenges
    • 5.1.4.1. Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
    • 5.1.4.2. High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Body Contouring Market, by Treatment Type

• 6.1. Introduction
• 6.2. Invasive
  • 6.2.1. Lower Body Lift
  • 6.2.2. Traditional Liposuction
  • 6.2.3. Tummy Tuck
• 6.3. Minimally Invasive
  • 6.3.1. Laser-Assisted Liposuction
  • 6.3.2. Radiofrequency-Assisted Liposuction
• 6.4. Non-Invasive
  • 6.4.1. Cryolipolysis
  • 6.4.2. High-Intensity Focused Ultrasound (HIFU)
  • 6.4.3. Laser Lipolysis
  • 6.4.4. Radiofrequency

7. Body Contouring Market, by Technology

• 7.1. Introduction
• 7.2. Cryolipolysis
• 7.3. Injectables
• 7.4. Laser
• 7.5. Radiofrequency
• 7.6. Ultrasound

8. Body Contouring Market, by End-User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Medical Spas
• 8.4. Specialty Clinics

9. Body Contouring Market, by Application

• 9.1. Introduction
• 9.2. Abdomen
• 9.3. Arms
• 9.4. Body & Back
• 9.5. Buttocks
• 9.6. Thighs

10. Body Contouring Market, by Product Type

• 10.1. Introduction
• 10.2. Consumables
• 10.3. Devices

11. Americas Body Contouring Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Body Contouring Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Body Contouring Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aerolase
• 2. Allergan
• 3. Alma Lasers
• 4. BTL Aesthetics
• 5. Cutera
• 6. Cynosure
• 7. EndyMed
• 8. Fotona
• 9. Galderma
• 10. Hologic
• 11. InMode
• 12. Lumenis
• 13. Merz Pharma
• 14. Sciton
• 15. Solta Medical
• 16. Syneron Medical
• 17. ThermiGen
• 18. Valeant Pharmaceuticals
• 19. Venus Concept
• 20. Zimmer Aesthetics